Kentaro Nakai

Kentaro Nakai

Auto-generated profile, based on publicly available information

Kentaro Nakai

Division of Nephrology and Dialysis Center, Japanese Red Cross Fukuoka Hospital

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2011 in Therapeutic Apheresis and Dialysis
Verified
Journal Article
Open access
PDF file
HFHideki Fujii
Hideki Fujii
KNKentaro Nakai
Kentaro Nakai
MFMasafumi Fukagawa
Masafumi Fukagawa
Several abnormalities of the cardiovascular system are observed in most cases of chronic kidney disease (CKD). Mechanisms underlying these abnormalities are complicated, and several factors contribute to their pathogenesis. Of these factors, oxidative stress and uremic toxins are considered to play key roles in the progression of cardiovascular disease (CVD) in CKD. Oxidative stress increases significantly in CKD and accelerates proteinuria and renal dysfunction. In addition, oxidative stress has been reported to induce cardiac hypertrophy and fibrosis. Indoxyl sulfate, a uremic toxin, has recently been suggested to play a crucial role in the development of CVD. Recent in vitro data suggest that indoxyl sulfate increases oxidative stress. Some reports have shown that AST‐120, which is an oral charcoal adsorbent, can reduce oxidative stress by lowering serum indoxyl sulfate levels. Recently, we have also demonstrated that indoxyl sulfate is associated with the production of oxidative stress, and that increased oxidative stress is significantly correlated with cardiac hypertrophy and fibrosis. Furthermore, results of our basic and clinical studies suggested that AST‐120 can prevent progression of cardiac hypertrophy by reducing oxidative stress in CKD. Thus, one of the main targets of the management of CKD and CVD is the control of oxidative stress and uremic toxins, such as indoxyl sulfate.

1 August 2012 in Kidney International
Verified
Journal Article
Closed access
KKKeiji Kono
Keiji Kono
HFHideki Fujii
Hideki Fujii
KNKentaro Nakai
Kentaro Nakai
SGShunsuke Goto
Shunsuke Goto
JSJunya Shite
Junya Shite
SNShinichi Nishi
Shinichi Nishi

12 March 2010 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
HFHideki Fujii
Hideki Fujii
KKKeiji Kono
Keiji Kono
KNKentaro Nakai
Kentaro Nakai
SGShunsuke Goto
Shunsuke Goto
HKHirotaka Komaba
Hirotaka Komaba
MFMasafumi Fukagawa
Masafumi Fukagawa
Background: The role of nitric oxide (NO) is controversial in diabetes nephropathy progression and the mechanisms remain unknown, especially in non-obese type 2 diabetes. To examine mechanisms of nephropathy progression in non-obese type 2 diabetes, we used spontaneously diabetic Torii (SDT) rats, a newly established model of non-obese type 2 diabetes. Methods: Fourteen male Sprague-Dawley rats were used as a control (20 weeks, n = 6; 30 weeks, n = 8), and 20-week-old male SDT rats were divided into 2 groups: diabetic (DM, n = 8) and DM + insulin (n = 8) groups. Twenty- and 36-week-old rats were sacrificed, and blood, urine, and histomorphometric analyses, mRNA expression analysis of endothelial NO synthase (eNOS) and NADPH oxidase, and blood pressure measurement were performed. Results: At 36 weeks, NO metabolites, and 8-hydroxydeoxyguanosine (8-OHdG) were significantly higher in the diabetic group than in the other 2 groups. Further renal studies showed increased glomerular volume and mesangial area, and intensified eNOS, 8-OHdG, and nitrotyrosine immunostaining in the diabetic group. Oxidative and nitrosative stress were positively associated with increased glomerular volume and mesangial area, which were mostly recovered by insulin therapy. Conclusions: NO and oxidative stress increased in SDT rats, suggesting that these play key roles in nephropathy progression in non-obese type 2 diabetes.

7 February 2013 in American Journal of Nephrology
Verified
Journal Article
Closed access
PDF file
KKKeiji Kono
Keiji Kono
HFHideki Fujii
Hideki Fujii
KNKentaro Nakai
Kentaro Nakai
SGShunsuke Goto
Shunsuke Goto
RKRiko Kitazawa
Riko Kitazawa
SNShinichi Nishi
Shinichi Nishi
Background/Aims: Vascular disease is one of the critical complications of diabetes. A growing body of evidence suggests that oxidative stress plays a key role for vascular disease progression. Recent studies have demonstrated a strong link between vitamin D and cardiovascular disease. Methods: We investigated the anti-oxidative effects of a vitamin D analog, 22-oxacalcitriol (maxacalcitol), on vascular lesions in type 2 diabetic rats. We used Spontaneously Diabetic Torii (SDT) rats, a model of non-obese type 2 diabetes. At 20 weeks of age, SDT rats were randomly divided into three groups: diabetes mellitus (DM, n = 10), DM + maxacalcitol (DM + D, n = 10), and DM + insulin (DM + I, n = 10). The rats were sacrificed at 30 weeks for the evaluation of blood and urine samples as well as histopathology and mRNA expression in the aorta. Results: Urinary 8-hydroxydeoxyguanosine (8-OHdG) excretion and the number of 8-OHdG-positive cells were significantly lower in the DM + I and DM + D groups than in the DM group. Real-time polymerase chain reaction analysis demonstrated that NADPH p22 phox and NADPH p47 phox mRNA levels were markedly decreased in the DM + I and DM + D groups compared with the DM group. Furthermore, the mRNA expression of MCP-1, ICAM-1 and VCAM-1 was significantly reduced in the DM + I and DM + D groups compared with the DM group. Conclusion: Our results suggest that the vasoprotective effects of vitamin D are mediated by reducing oxidative stress.

1 March 2014 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
SGShunsuke Goto
Shunsuke Goto
KNKentaro Nakai
Kentaro Nakai
KKKeiji Kono
Keiji Kono
YYYuriko Yonekura
Yuriko Yonekura
JIJun Ito
Jun Ito
SNShinichi Nishi
Shinichi Nishi

26 October 2012 in Clinical and Experimental Nephrology
Verified
Journal Article
Closed access
PDF file
SGShunsuke Goto
Shunsuke Goto
KKKen Kitamura
Ken Kitamura
KKKeiji Kono
Keiji Kono
KNKentaro Nakai
Kentaro Nakai
HFHideki Fujii
Hideki Fujii
SNShinichi Nishi
Shinichi Nishi